Table 2:

Patient characteristics of the 181 HCV-viremic patients enrolled in the first surveillance.

Age (years)	66.1 ± 10.0
Female	86 (47.5)
BMI before dialysis (kg/m2)	23.5 ± 4.2
BMI after dialysis (kg/m2)	22.6 ± 4.1
HBsAg (+)	12 (6.6)
HCV RNA, log (IU/mL)	5.5 ± 1.2
HCV genotype (1a/1b/2/6/mixed/unclassified)	5 (2.8)/73 (40.3)/88 (48.6)/12 (6.6)/2 (1.1)/1 (0.6)
WBC (×1000/µL)	6.5 ± 2.2
Hemoglobin (g/dL)	10.5 ± 1.5
Platelet count (×1000/µL)	174.0 ± 66.2
AST (U/L)	27.5 ± 17.7
ALT (U/L)	28.2 ± 31.9
Albumin (g/dL)	3.9 ± 0.4
FIB-4	2.5 ± 2.2
APRI	0.5 ± 0.5
Fibroscan (kPa)a	9.4 ± 4.8
Fibroscan >12 kPaa	24 (22.2)
Diabetes	105 (58.0)
Hypertension	123 (68.0)
Dyslipidemia	44 (24.3)
Cerebrovascular disease	20 (11.0)
Cardiovascular disease	92 (50.8)
Systemic lupus erythematosus	4 (2.2)
Hepatocellular carcinoma	11 (6.1)
Other malignancy	15 (16.3)

Data are expressed as mean ± standard deviation or n (%).

^a n = 108.

BMI: body mass index; kPa: kilopascal; WBC: white blood cell.